
Low energy? Test before you treat
What we discuss after bloodwork, not before it.
Enclomiphene is a medication that is compounded, prescription only, not FDA-approved.
Also known as Enclomiphene citrate, Androxal
Enclomiphene is one half of clomiphene, a fertility drug. It blocks estrogen feedback in the brain so the body makes more of its own testosterone, which is why men who want to keep fertility ask about it.
In 1 example journal

Made by a licensed compounding pharmacy for an individual prescription. Compounded drugs are not FDA-approved, so quality depends on the pharmacy. Not FDA-approved (the original developer's applications did not win approval). Enclomiphene citrate is in FDA's 503A Category 1 (under evaluation), so pharmacies can compound it for an individual prescription under FDA's interim policy.
As of September 23, 2026.
Key takeaways
Enclomiphene is one half of clomiphene, an older fertility drug. It blocks estrogen's "slow down" signal in the brain, so the pituitary releases more LH and FSH. Those hormones tell the testes to make more testosterone and keep making sperm.
Because it depends on the brain-to-testes signal, it only makes sense when the testes can still respond. It is not expected to help when the testes themselves are the problem.



Randomized trials, including phase 3, show it raises testosterone levels and preserves sperm counts; evidence on symptoms and long-term safety is limited.
What trials and prescribing information measured over time. Everyone responds differently.
In early trials, testosterone and LH levels had risen within about six weeks.
In phase 3 trials, average testosterone was in the normal range at about 16 weeks, and sperm counts were stable or slightly higher. Effects on symptoms were not well measured.
Clinicians see enclomiphene as a way to raise testosterone while protecting fertility, but it has no FDA approval and limited long-term data, and its compounding status could change.
The AUA guideline says clinicians may use selective estrogen receptor modulators (the drug class enclomiphene belongs to), hCG or aromatase inhibitors in men with low testosterone who want to keep their fertility. This is off-label use, and the guideline does not name enclomiphene.
AUA: Testosterone Deficiency guideline (2018, validity confirmed 2024)Enclomiphene citrate is in Category 1 (under evaluation) on FDA's 503A list dated May 14, 2026, which is why pharmacies can compound it for now.
FDA: 503A bulk drug substance categories list (May 14, 2026)In a phase 3 program, enclomiphene raised testosterone into the normal range while sperm counts held steady; in the same studies, testosterone gel lowered sperm counts.
Enclomiphene phase 3: raises testosterone and preserves sperm counts (BJU Int 2016)Clomiphene-type drugs are prohibited at all times in tested sport under the WADA list.
WADA 2026 Prohibited List (as published in the Austrian Federal Law Gazette)Summaries of published guidelines, drug labels, regulators and reviews, each attributed to its source. DiscoverMedica does not employ clinicians.
Only a licensed clinician who knows your history can decide whether it is right for you.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Complete an online questionnaire about symptoms, history and fertility plans.
Do a baseline hormone test, usually an at-home kit or a lab draw; some programs accept recent labs.
A licensed clinician reviews your results. Some states require a video visit.
If prescribed, a compounding pharmacy ships the capsules to you.
Expect a recheck of hormone levels after a few months.
Some services let you order common lab tests yourself, so the results are ready for your visit. Your clinician decides which labs, if any, you need, and what the results mean.
From each service’s own site, checked September 23, 2026.
From each provider’s own site, checked September 23, 2026. Programs change, so confirm the details before you sign up.
6 providers list Enclomiphene on DiscoverMedica, lowest listed price first.
† Prices as listed by the provider when we checked; they change.
Listed prices run from $42 to $99.99 a month across 4 providers, as checked October 7, 2026.
Prices as listed by the provider when we checked; they change. Membership or consult fees may be separate; see each provider.
Testosterone therapy replaces the hormone and usually shuts down sperm production. Enclomiphene prompts your own body to make more testosterone, and trials found sperm counts held steady.
No. FDA declined to approve it in 2015 and asked for more studies. It is available only from compounding pharmacies, which FDA does not review product by product.
Possibly. It sits in a temporary FDA category that allows compounding while FDA evaluates it, and an FDA advisory committee voted in 2022 against adding it to the permanent list.
Headache, hot flashes, mood changes and nausea are reported. Clomiphene-type drugs have also been linked to vision changes and blood clots.
Yes, several men's health providers prescribe compounded enclomiphene after an online intake and hormone labs.
This is not a complete list of risks. Talk to a licensed clinician or pharmacist about your own situation. If you have a severe reaction, call 911. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.
Guide reviewed September 23, 2026.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.

What we discuss after bloodwork, not before it.
A prescription pill that slows male-pattern hair loss by lowering DHT.
Prescription testosterone replacement for men with confirmed low testosterone.
A reproductive-hormone peptide studied in fertility research. Restricted from compounding.
A peptide that prompts your pituitary to release growth hormone. Available compounded.